At this time early research in general shows the plus side of these medications outweighs some potential side effects. In this The risk of diabetic retinopathy came with the results of the SUSTAIN 6 trial, the first that compared the effect of semaglutide in cardiovascular outcomes in subjects with type 2 diabetes, Fernando Gerchman, MD, PhD, professor of medicine in the Division of Endocrinology and Metabolism at the Hospital de Clnicas de Porto Alegre in Brazil and senior author of this study, told MNT
Should you be using AI for health advice
The choice of alternative treatment should be individualized, considering the patients specific health needs, their tolerance to different medications, and their overall treatment goals
By integrating GLP-1 treatments with personalized care, expert guidance, and a supportive environment, we create a weight loss experience that prioritizes your health and long-term goals